156 related articles for article (PubMed ID: 2649630)
1. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages.
Becker S; Devlin RB; Haskill JS
J Leukoc Biol; 1989 Apr; 45(4):353-61. PubMed ID: 2649630
[TBL] [Abstract][Full Text] [Related]
2. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.
Janson RW; Hance KR; Arend WP
J Immunol; 1991 Dec; 147(12):4218-23. PubMed ID: 1836481
[TBL] [Abstract][Full Text] [Related]
3. Muramyl dipeptide induces production of hemopoietic growth factors in vivo by a mechanism independent of tumor necrosis factor.
Broudy VC; Kaushansky K; Shoemaker SG; Aggarwal BB; Adamson JW
J Immunol; 1990 May; 144(10):3789-94. PubMed ID: 1692060
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumor necrosis factor-alpha production and gene expression in monocytes.
Kohn FR; Phillips GL; Klingemann HG
Bone Marrow Transplant; 1992 May; 9(5):369-76. PubMed ID: 1617321
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of human monocytes via CD45, CD44, and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-1 beta.
Gruber MF; Webb DS; Gerrard TL
J Immunol; 1992 Feb; 148(4):1113-8. PubMed ID: 1371132
[TBL] [Abstract][Full Text] [Related]
6. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.
Becker S; Quay J; Soukup J
J Immunol; 1991 Dec; 147(12):4307-12. PubMed ID: 1753101
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha.
van Lenten BJ; Fogelman AM
J Immunol; 1992 Jan; 148(1):112-6. PubMed ID: 1727858
[TBL] [Abstract][Full Text] [Related]
8. Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor.
Strassmann G; Bertolini DR; Kerby SB; Fong M
J Immunol; 1991 Aug; 147(4):1279-85. PubMed ID: 1869823
[TBL] [Abstract][Full Text] [Related]
9. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
Sirko SP; Schindler R; Doyle MJ; Weisman SM; Dinarello CA
Eur J Immunol; 1991 Feb; 21(2):243-50. PubMed ID: 1847874
[TBL] [Abstract][Full Text] [Related]
10. Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing.
Herzyk DJ; Allen JN; Marsh CB; Wewers MD
J Immunol; 1992 Nov; 149(9):3052-8. PubMed ID: 1401931
[TBL] [Abstract][Full Text] [Related]
11. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently.
Arend WP; Smith MF; Janson RW; Joslin FG
J Immunol; 1991 Sep; 147(5):1530-6. PubMed ID: 1831827
[TBL] [Abstract][Full Text] [Related]
12. Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages.
Bermudez LE; Wu M; Martinelli J; Young LS
Lymphokine Cytokine Res; 1991 Oct; 10(5):413-9. PubMed ID: 1662988
[TBL] [Abstract][Full Text] [Related]
13. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.
DeForge LE; Kenney JS; Jones ML; Warren JS; Remick DG
J Immunol; 1992 Apr; 148(7):2133-41. PubMed ID: 1545121
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1.
Sone S; Yanagawa H; Nishioka Y; Orino E; Bhaskaran G; Nii A; Mizuno K; Heike Y; Ogushi F; Ogura T
Eur Respir J; 1992 Feb; 5(2):174-81. PubMed ID: 1559582
[TBL] [Abstract][Full Text] [Related]
15. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages.
Cavaillon JM; Fitting C; Haeffner-Cavaillon N
Eur J Immunol; 1990 Feb; 20(2):253-7. PubMed ID: 1690130
[TBL] [Abstract][Full Text] [Related]
16. Production of interleukin-1 and tumor necrosis factor by cisplatin-treated murine peritoneal macrophages.
Singh RK; Sodhi A; Singh SM
Nat Immun Cell Growth Regul; 1991; 10(2):105-16. PubMed ID: 1881399
[TBL] [Abstract][Full Text] [Related]
17. [Induction of tumor cell killing by human alveolar macrophages and its regulation by IL-4].
Sone S; Nishioka Y; Nii A; Yanagawa H; Orino E; Mizuno K; Yano S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():207-12. PubMed ID: 1306226
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma cells constitutively produce granulocyte colony-stimulating factor.
Pietsch T; Mempel K; Menzel T; Ockler R; Welte K
Klin Padiatr; 1990; 202(4):235-9. PubMed ID: 1697636
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers.
Bonfield TL; Colton E; Marchant RE; Anderson JM
J Biomed Mater Res; 1992 Jul; 26(7):837-50. PubMed ID: 1607370
[TBL] [Abstract][Full Text] [Related]
20. [Immunological status of alveolar macrophages in patients with lung cancer and benign pulmonary diseases].
Liu C
Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):408-11, 446. PubMed ID: 1330230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
